Optimal strategies of oncolytic virus-bortezomib therapy via the apoptotic, necroptotic, and oncolysis signaling network

Bortezomib and oncolytic virotherapy are two emerging targeted cancer therapies. Bortezomib, a proteasome inhibitor, disrupts protein degradation in cells, leading to the accumulation of unfolded proteins that induce apoptosis. On the other hand, virotherapy uses genetically modified oncolytic virus...

Full description

Bibliographic Details
Main Authors: Donggu Lee, Aurelio A. de los Reyes V, Yangjin Kim
Format: Article
Language:English
Published: AIMS Press 2024-02-01
Series:Mathematical Biosciences and Engineering
Subjects:
Online Access:https://www.aimspress.com/article/doi/10.3934/mbe.2024173?viewType=HTML

Similar Items